González, L.O.; Eiro, N.; Fraile, M.; Sánchez, R.; Andicoechea, A.; Fernández-Francos, S.; Schneider, J.; Vizoso, F.J.
Joint Tumor Bud–MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma. Biomedicines 2021, 9, 196.
https://doi.org/10.3390/biomedicines9020196
AMA Style
González LO, Eiro N, Fraile M, Sánchez R, Andicoechea A, Fernández-Francos S, Schneider J, Vizoso FJ.
Joint Tumor Bud–MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma. Biomedicines. 2021; 9(2):196.
https://doi.org/10.3390/biomedicines9020196
Chicago/Turabian Style
González, Luis O., Noemi Eiro, María Fraile, Rosario Sánchez, Alejandro Andicoechea, Silvia Fernández-Francos, Jose Schneider, and Francisco J. Vizoso.
2021. "Joint Tumor Bud–MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma" Biomedicines 9, no. 2: 196.
https://doi.org/10.3390/biomedicines9020196
APA Style
González, L. O., Eiro, N., Fraile, M., Sánchez, R., Andicoechea, A., Fernández-Francos, S., Schneider, J., & Vizoso, F. J.
(2021). Joint Tumor Bud–MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma. Biomedicines, 9(2), 196.
https://doi.org/10.3390/biomedicines9020196